Synergistic induction of apoptosis in resistant head and neck carcinoma and leukemia by alkoxyamide-based histone deacetylase inhibitors-Reference-Cited by-同舟云学术

Synergistic induction of apoptosis in resistant head and neck carcinoma and leukemia by alkoxyamide-based histone deacetylase inhibitors

Published:2021-02 Issue: Volume:211 Page:113095
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Alves Avelar Leandro A.,Schrenk Christian,Sönnichsen Melf,Hamacher Alexandra,Hansen Finn K.^ORCID,Schliehe-Diecks Julian,Borkhardt Arndt,Bhatia Sanil,Kassack Matthias U.,Kurz Thomas

Funder

CAPES

Deutsche Forschungsgemeinschaft

German Cancer Aid

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference37 articles.

1. Epigenetics in cancer;Sharma;Carcinogenesis,2009

2. Understanding the complexity of epigenetic target space;Pande;J. Med. Chem.,2016

3. Lysine acetylation goes global: from epigenetics to metabolism and therapeutics;Ali;Chem. Rev.,2018

4. Molecular evolution of the histone deacetylase Family : functional implications of phylogenetic analysis;Gregoretti;J. Mol. Biol.,2004

5. FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma;Mann;Oncology,2007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Antioxidant and HDAC-Inhibitor α-Lipoic Acid Is Synergistic with Exemestane in Estrogen Receptor-Positive Breast Cancer Cells;International Journal of Molecular Sciences;2024-08-02

2. Activity of alkoxyamide-based histone deacetylase inhibitors against Plasmodium falciparum malaria parasites;Experimental Parasitology;2024-03

3. Design, synthesis and biological evaluation of novel imidazole-based benzamide and hydroxamic acid derivatives as potent histone deacetylase inhibitors and anticancer agents;Journal of Molecular Structure;2024-02

4. Technologies of targeting histone deacetylase in drug discovery: Current progress and emerging prospects;European Journal of Medicinal Chemistry;2023-12

5. Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells;International Journal of Molecular Sciences;2023-03-14